Skip to main content
Log in

A 2019 update on TSH-secreting pituitary adenomas

  • Short Review
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thyrotropin-secreting pituitary adenomas (TSH-omas) present with signs and symptoms of hyperthyroidism and they are characterized by elevated serum levels of free thyroid hormones with measurable TSH levels. TSH-omas are very infrequent, accounting for less than 1% of all pituitary adenomas, thus representing a very rare cause of hyperthyroidism. For this reason, data collected on these rare disorders are relatively few, but some new researches shed new light on the etiopathogenesis, the diagnosis and the treatment of such a remarkable disease. Since the same biochemical picture is present in the syndromes of thyroid hormone resistance (RTH), in particular in the form of pituitary RTH, failure in distinguishing these clinical entities may lead to improper patient management. Conversely, early diagnosis and correct treatment of TSH-omas may prevent the occurrence of neurological and endocrinological complications, thus leading to a better rate of cure. In the present short review article, the most relevant recent advances in the pathophysiology of TSH-omas are described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beck-Peccoz P, Lania A, Persani L (2015) Chapter 24. TSH-producing adenomas. In: Jameson JL, DeGroot LJ (eds) Endocrinology, 7th edn. W.B. Saunders Pub, Philadelphia, pp 266–274

    Google Scholar 

  2. Beck-Peccoz P, Persani L, Lania A (2000) Thyrotropin-secreting pituitary adenomas. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP (eds) Endotext. MDText.com Inc, South Dartmouth, MA

    Google Scholar 

  3. Gurnell M, Visser TJ, Beck-Peccoz P, Chatterjee VKK (2015) Resistance to thyroid hormone: in endocrinology, adult and pediatric. In: Jameson LJ, DeGroot LJ (eds), 7th edn, vol II. Elsevier, Philadelphia pp 1648–1665

  4. Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486

    Article  CAS  PubMed  Google Scholar 

  5. Bertholon-Grégoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519–527

    Article  PubMed  Google Scholar 

  6. Socin HV, Chanson P, Delemer B et al (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433–442

    Article  CAS  PubMed  Google Scholar 

  7. Yamada S, Fukuhara N, Horiguchi K et al (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121:1462–1473

    Article  PubMed  Google Scholar 

  8. van Varsseveld NC, Bisschop PH et al (2014) A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas. Clin Endocrinol (Oxf) 80:395–402

    Article  Google Scholar 

  9. Azzalin A, Appin CL, Schniederjan MJ et al (2016) Comprehensive evaluation of TSHomas: single-center 20-year experience. Pituitary 19:183–193

    Article  PubMed  Google Scholar 

  10. Tjörnstrand A, Nyström HF (2017) Diagnostic approach to TSH-producing pituitary adenoma. Eur J Endocrinol 177:R183–R197

    Article  PubMed  Google Scholar 

  11. Nazato DM, Abucham J (2018) Diagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference center. J Endocrinol Invest 41:447–454

    Article  CAS  PubMed  Google Scholar 

  12. Cossu G, Daniel RT, Pierzchala K et al (2019) Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management. Pituitary 22(1):79–88

    Article  CAS  PubMed  Google Scholar 

  13. Önnestam L, Berinder K, Burman P et al (2013) National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metab 98:626–635

    Article  CAS  PubMed  Google Scholar 

  14. Taylor TJ, Donlon SS, Bale AE et al (2000) Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1. Thyroid 10:1001–1007

    Article  CAS  PubMed  Google Scholar 

  15. Daly AF, Tichomirowa MA, Petrossians P et al (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373–E383

    Article  PubMed  Google Scholar 

  16. Pereira BD, Raimundo L, Mete O, Oliveira A, Portugal J, Asa SL (2016) Monomorphous plurihormonal pituitary adenoma of pit-1 lineage in a giant adolescent with central hyperthyroidism. Endocr Pathol 27:25–33

    Article  PubMed  Google Scholar 

  17. Li J, Li J, Jiang S, Yu R, Yu Y (2018) Case report of a pituitary TSH-secreting macroadenoma with Hashimoto thyroiditis and infertility. Medicine (Baltimore). 97:e9546

    Article  PubMed  PubMed Central  Google Scholar 

  18. Malchiodi E, Profka E, Ferrante E et al (2014) Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab 99:2069–2076

    Article  CAS  PubMed  Google Scholar 

  19. Sapkota S, Horiguchi K, Tosaka M, Yamada S, Yamada M (2017) Whole-exome sequencing study of thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 102:566–575

    PubMed  Google Scholar 

  20. Ando S, Sarlis NJ, Oldfield EH, Yen PM (2001) Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86:5572–5576

    CAS  PubMed  Google Scholar 

  21. Gatto F, Barbieri F, Gatti M et al (2012) Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins. Clin Endocrinol (Oxf) 76:407–414

    Article  CAS  Google Scholar 

  22. Lee W, Cheung AS, Freilich R (2012) TSH-secreting pituitary carcinoma with intrathecal drop metastases. Clin Endocrinol (Oxf) 76:604–606

    Article  CAS  Google Scholar 

  23. Pappa T, Papanastasiou L, Markou A et al (2010) Thyrotoxic periodic paralysis as the first manifestation of a thyrotropin-secreting pituitary adenoma. Hormones (Athens) 9:82–86

    Article  Google Scholar 

  24. Lee MT, Wang CY (2010) Concomitant Graves hyperthyroidism with thyrotrophin-secreting pituitary adenoma. South Med J 103:347–349

    Article  PubMed  Google Scholar 

  25. Abs R, Stevenaert A, Beckers A (1994) Autonomously functioning thyroid nodules in a patient with a thyrotropin-secreting pituitary adenoma: possible cause-effect relationship. Eur J Endocrinol 131:355–358

    Article  CAS  PubMed  Google Scholar 

  26. Perticone F, Pigliaru F, Mariotti S et al (2015) Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series. Thyroid 25:417–424

    Article  CAS  PubMed  Google Scholar 

  27. Koulouri O, Moran C, Halsall D, Chatterjee K, Gurnell M (2013) Pitfalls in the measurement and interpretation of thyroid function tests. Best Pract Res Clin Endocrinol Metab 27:745–762

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Schoenmakers N, Moran C, Campi I et al (2014) A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia. J Clin Endocrinol Metab 99:E1381–E1386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Favresse J, Burlacu MC, Maiter D, Gruson D (2018) Interferences with thyroid function immuno-assays: clinical implications and detection algorithm. Endocr Rev 4339:830–850

    Article  Google Scholar 

  30. Okuma H, Hashimoto K, Ohashi T et al (2018) A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels. Endocr J 65:737–746

    Article  CAS  PubMed  Google Scholar 

  31. Beck-Peccoz P, Persani L, Faglia G (1992) Glycoprotein hormone α-subunit in pituitary adenomas. Trends Endocrinol Metab 3:41–45

    Article  CAS  PubMed  Google Scholar 

  32. Mannavola D, Persani L, Vannucchi G et al (2005) Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) 62:176–181

    Article  CAS  Google Scholar 

  33. Song M, Wang H, Song L et al (2014) Ectopic TSH-secreting pituitary tumor: a case report and review of prior cases. BMC Cancer 14:544

    Article  PubMed  PubMed Central  Google Scholar 

  34. Wang Q, Lu XJ, Sun J, Wang J, Huang CY, Wu ZF (2016) Ectopic suprasellar TSH-secreting pituitary adenoma: case report and literature review. World Neurosurg 95(617):e13

    Google Scholar 

  35. Beck-Peccoz P, Lania A, Beckers A, Chatterjee K, Wemeau JL (2013) 2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors. Eur Thyroid J 2:76–82

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Sriphrapradang C, Srichomkwun P, Refetoff S, Mamanasiri S (2016) A Novel thyroid hormone receptor beta gene mutation (G251V) in a Thai patient with resistance to thyroid hormone coexisting with pituitary incidentaloma. Thyroid 26:1804–1806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Dyer MW, Gnagey A, Jones BT et al (2017) Perianesthetic management of patients with TSH-secreting pituitary adenomas. J Neurosurg Anesthesiol 29:341–346

    Article  PubMed  Google Scholar 

  38. Fukuhara N, Horiguchi K, Nishioka H et al (2015) Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma. Endocr J 62:21–27

    Article  CAS  PubMed  Google Scholar 

  39. Fujio S, Ashari Habu M, Yamahata H et al (2014) Thyroid storm induced by TSH-secreting pituitary adenoma: a case report. Endocr J 61:1131–1136

    Article  CAS  PubMed  Google Scholar 

  40. Daousi C, Foy PM, MacFarlane IA (2007) Ablative thyroid treatment for thyrotoxicosis due to thyrotropin-producing pituitary tumours. J Neurol Neurosurg Psychiatry 78:93–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Mouslech Z, Somali M, Sakali AK, Savopoulos C, Mastorakos G, Hatzitolios AI (2016) TSH-secreting pituitary adenomas treated by gamma knife radiosurgery: our case experience and a review of the literature. Hormones (Athens) 15:122–128

    Article  Google Scholar 

  42. Kuhn JM, Arlot S, Lefebvre H et al (2000) Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85:1487–1491

    Article  CAS  PubMed  Google Scholar 

  43. Blackhurst G, Strachan MW, Collie D et al (2002) The treatment of a TSH-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 57:401–404

    Article  CAS  Google Scholar 

  44. Losa M, Giovanelli M, Persani L, Faglia G, Beck-Peccoz P (1996) Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81:3086–3090

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Lania.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

There is no identifying patient information present in this manuscript; therefore, informed consent is unnecessary.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beck-Peccoz, P., Giavoli, C. & Lania, A. A 2019 update on TSH-secreting pituitary adenomas. J Endocrinol Invest 42, 1401–1406 (2019). https://doi.org/10.1007/s40618-019-01066-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-019-01066-x

Keywords

Navigation